HEADER PROTEIN BINDING 05-APR-00 1E0Q TITLE MUTANT PEPTIDE FROM THE FIRST N-TERMINAL 17 AMINO-ACID OF TITLE 2 UBIQUITIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYUBIQUITIN-B; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-17; COMPND 5 SYNONYM: UBIQUITIN; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 4 ORGANISM_COMMON: CATTLE; SOURCE 5 ORGANISM_TAXID: 9913 KEYWDS PROTEIN BINDING, MUTANT PEPTIDE EXPDTA SOLUTION NMR NUMMDL 27 AUTHOR R.ZERELLA,P.Y.CHEN,P.A.EVANS,A.RAINE,D.H.WILLIAMS REVDAT 4 15-MAY-13 1E0Q 1 COMPND JRNL REMARK ATOM REVDAT 4 2 TER MASTER REVDAT 3 07-NOV-12 1E0Q 1 HEADER COMPND SOURCE KEYWDS REVDAT 3 2 JRNL REMARK VERSN DBREF REVDAT 3 3 SEQADV REVDAT 2 24-FEB-09 1E0Q 1 VERSN REVDAT 1 16-JAN-01 1E0Q 0 JRNL AUTH R.ZERELLA,P.Y.CHEN,P.A.EVANS,A.RAINE,D.H.WILLIAMS JRNL TITL STRUCTURAL CHARACTERIZATION OF A MUTANT PEPTIDE DERIVED JRNL TITL 2 FROM UBIQUITIN: IMPLICATIONS FOR PROTEIN FOLDING. JRNL REF PROTEIN SCI. V. 9 2142 2000 JRNL REFN ISSN 0961-8368 JRNL PMID 11152124 JRNL DOI 10.1110/PS.9.11.2142 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.8 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 THE JRNL CITATION ABOVE REMARK 4 REMARK 4 1E0Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-00. REMARK 100 THE PDBE ID CODE IS EBI-4820. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 275 REMARK 210 PH : 3.8 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 10% WATER/90% D2O AND 90% REMARK 210 WATER/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; COSY; TOCSY; ROESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX500; DRX600 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XPLOR 3.8 REMARK 210 METHOD USED : SIMULATED ANNEALING FROM REMARK 210 RANDOM COORDINATES REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 60 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 27 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 8 REMARK 210 REMARK 210 REMARK: THE STRUCTURE WAS DETERMINED USING 2D NMR REMARK 210 SPECTROSCOPY ON A NON-LABELLED SAMPLE. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 1 PHE A 4 CD1 PHE A 4 CE1 0.124 REMARK 500 1 PHE A 4 CD2 PHE A 4 CE2 0.128 REMARK 500 1 PHE A 4 CE1 PHE A 4 CZ 0.148 REMARK 500 1 PHE A 4 CE2 PHE A 4 CZ 0.149 REMARK 500 1 PHE A 4 CG PHE A 4 CD1 0.163 REMARK 500 1 PHE A 4 CG PHE A 4 CD2 0.142 REMARK 500 2 PHE A 4 CD1 PHE A 4 CE1 0.124 REMARK 500 2 PHE A 4 CD2 PHE A 4 CE2 0.129 REMARK 500 2 PHE A 4 CE1 PHE A 4 CZ 0.147 REMARK 500 2 PHE A 4 CE2 PHE A 4 CZ 0.148 REMARK 500 2 PHE A 4 CG PHE A 4 CD1 0.163 REMARK 500 2 PHE A 4 CG PHE A 4 CD2 0.142 REMARK 500 3 PHE A 4 CD1 PHE A 4 CE1 0.123 REMARK 500 3 PHE A 4 CD2 PHE A 4 CE2 0.129 REMARK 500 3 PHE A 4 CE1 PHE A 4 CZ 0.147 REMARK 500 3 PHE A 4 CE2 PHE A 4 CZ 0.149 REMARK 500 3 PHE A 4 CG PHE A 4 CD1 0.164 REMARK 500 3 PHE A 4 CG PHE A 4 CD2 0.142 REMARK 500 4 PHE A 4 CD1 PHE A 4 CE1 0.123 REMARK 500 4 PHE A 4 CD2 PHE A 4 CE2 0.127 REMARK 500 4 PHE A 4 CE1 PHE A 4 CZ 0.148 REMARK 500 4 PHE A 4 CE2 PHE A 4 CZ 0.148 REMARK 500 4 PHE A 4 CG PHE A 4 CD1 0.162 REMARK 500 4 PHE A 4 CG PHE A 4 CD2 0.144 REMARK 500 5 PHE A 4 CD1 PHE A 4 CE1 0.125 REMARK 500 5 PHE A 4 CD2 PHE A 4 CE2 0.127 REMARK 500 5 PHE A 4 CE1 PHE A 4 CZ 0.149 REMARK 500 5 PHE A 4 CE2 PHE A 4 CZ 0.149 REMARK 500 5 PHE A 4 CG PHE A 4 CD1 0.160 REMARK 500 5 PHE A 4 CG PHE A 4 CD2 0.146 REMARK 500 6 PHE A 4 CD1 PHE A 4 CE1 0.125 REMARK 500 6 PHE A 4 CD2 PHE A 4 CE2 0.127 REMARK 500 6 PHE A 4 CE1 PHE A 4 CZ 0.147 REMARK 500 6 PHE A 4 CE2 PHE A 4 CZ 0.149 REMARK 500 6 PHE A 4 CG PHE A 4 CD1 0.159 REMARK 500 6 PHE A 4 CG PHE A 4 CD2 0.149 REMARK 500 7 PHE A 4 CD1 PHE A 4 CE1 0.123 REMARK 500 7 PHE A 4 CD2 PHE A 4 CE2 0.128 REMARK 500 7 PHE A 4 CE1 PHE A 4 CZ 0.148 REMARK 500 7 PHE A 4 CE2 PHE A 4 CZ 0.148 REMARK 500 7 PHE A 4 CG PHE A 4 CD1 0.164 REMARK 500 7 PHE A 4 CG PHE A 4 CD2 0.141 REMARK 500 8 PHE A 4 CD1 PHE A 4 CE1 0.125 REMARK 500 8 PHE A 4 CD2 PHE A 4 CE2 0.126 REMARK 500 8 PHE A 4 CE1 PHE A 4 CZ 0.147 REMARK 500 8 PHE A 4 CE2 PHE A 4 CZ 0.147 REMARK 500 8 PHE A 4 CG PHE A 4 CD1 0.159 REMARK 500 8 PHE A 4 CG PHE A 4 CD2 0.150 REMARK 500 9 PHE A 4 CD1 PHE A 4 CE1 0.124 REMARK 500 9 PHE A 4 CD2 PHE A 4 CE2 0.126 REMARK 500 REMARK 500 THIS ENTRY HAS 162 BOND DEVIATIONS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 2 LEU A 8 -18.70 79.09 REMARK 500 3 ASP A 9 -42.35 -140.35 REMARK 500 7 LEU A 8 -18.86 79.05 REMARK 500 21 LEU A 8 -9.34 75.78 REMARK 500 24 LEU A 8 -10.31 77.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AAR RELATED DB: PDB REMARK 900 UBIQUITIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 THR 9 HAS BEEN REPLACED BY ASP DBREF 1E0Q A 1 17 UNP P0CG53 UBB_BOVIN 1 17 SEQADV 1E0Q ASP A 9 UNP P0CG53 THR 9 ENGINEERED MUTATION SEQRES 1 A 17 MET GLN ILE PHE VAL LYS THR LEU ASP GLY LYS THR ILE SEQRES 2 A 17 THR LEU GLU VAL SHEET 1 A 2 GLN A 2 THR A 7 0 SHEET 2 A 2 LYS A 11 GLU A 16 -1 O LYS A 11 N THR A 7 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1